✦ LIBER ✦

Fluid Restriction in the Management of Decompensated Heart Failure: No Impact on Time to Clinical Stability

✍ Scribed by Bronagh Travers; Christina O'Loughlin; Niamh F. Murphy; Mary Ryder; Carmel Conlon; Mark Ledwidge; Kenneth McDonald

Book ID: 119214369
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 153 KB
Volume: 13
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2006.10.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incremental value of biomarkers to clini

Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study

✍ Lassus, Johan; Gayat, Etienne; Mueller, Christian; Peacock, W.Frank; Spinar, Jin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 1014 KB

Impact of Ejection Fraction on the Clini

Impact of Ejection Fraction on the Clinical Response to Cardiac Resynchronization Therapy in Mild Heart Failure

✍ Linde, C.; Daubert, C.; Abraham, W. T.; St John Sutton, M.; Ghio, S.; Hassager, 📂 Article 📅 2013 🏛 Ovid Technologies Wolters Kluwer -American Heart A 🌐 English ⚖ 737 KB

TIME TO INTRAVENOUS THERAPY AND CLINICAL

TIME TO INTRAVENOUS THERAPY AND CLINICAL OUTCOMES IN OLDER PATIENTS PRESENTING WITH ACUTE DECOMPENSATED HEART FAILURE: AN ANALYSIS OF THE ADHERE REGISTRY EMERGENCY MODULE

✍ Wong, Yee Weng; Fonarow, Gregg C.; Mi, Xiaojuan; Mills, Roger M.; Peacock IV, Fr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 146 KB

IMPACT OF CHANGES IN BLOOD PRESSURE DURI

IMPACT OF CHANGES IN BLOOD PRESSURE DURING THE TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE ON RENAL AND CLINICAL OUTCOMES: AN APPLICATION OF THE ESCAPE TRIAL LIMITED DATASET

✍ Jeffrey M. Testani; Thomas P. Cappola; James Shen; Richard P. Shannon; Stephen E 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Pre-discharge initiation of carvedilol i

Pre-discharge initiation of carvedilol in patients stabilized during an admission for decompensated heart failure is a safe and effective strategy to improve the use of beta-blocker therapy: results of the IMPACT-HF trial

✍ Mihai Gheorghiade; Wendy A Gattis; Dianne S Gallup; A.Bleakley Chandler; A.Alan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Reply to the letter by Dr Erqou regardin

Reply to the letter by Dr Erqou regarding “Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients”

✍ Davide Castagno; Jonathan Baird-Gunning; Pardeep S. Jhund; Giuseppe Biondi Zocca 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB